LOGIN  |  REGISTER
Assertio
Amneal Pharmaceuticals

DBV Technologies: Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

April 04, 2024 | Last Trade: US$10.83 0.16 -1.46

DBV Technologies - Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
03/31/2024

 
96,434,369

 
 

Total gross of voting rights: 96,434,369

 
 

Total net* of voting rights: 96,171,725

 

* Net total = total number of voting rights attached to shares – shares without voting rights

Terns Pharmaceuticals

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page